Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An NIH-wide notice appears above the page, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:09:37.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The study-record page displays a 403 Forbidden message with a Home link, and the site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.6%
    Check dated 2026-10-10T15:46:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study record content with a minimal header and a Home link, indicating the page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T17:31:22.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This blocks access to the study details and locations, replacing the previous information with a standard error page.
    Difference
    17%
    Check dated 2026-09-19T22:21:15.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A minor site revision was applied: 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' removed, reflecting a backend/UI update without changes to study data or disclosures.
    Difference
    0.1%
    Check dated 2026-08-29T20:42:07.000Z thumbnail image

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.